Latest Operational Restructuring News

MyEco Group Ltd reported an 8.6% rise in FY25 sales driven by strong growth in its global MyEco® product line and new UK retail partnerships, while navigating challenges in resin markets and US tariffs.

Jatcorp anticipates a significant net loss for FY2025 driven by halted sales in China and legal disputes, yet remains cautiously optimistic about growth prospects in FY2026.

Netlinkz Limited reports $4.8 million in quarterly customer receipts, exits Starlink operations, and pivots to a joint venture in the Philippines to drive growth across ASEAN markets.

SRJ Technologies Group has voluntarily suspended its ASX trading as it prepares for a pivotal capital raising and shareholder meeting to secure its financial future.

Advance ZincTek Limited reports a remarkable shift from loss to profit in FY25, driven by stronger US sales and operational efficiencies after closing Perth facilities.

Advance ZincTek Limited signals a strong financial turnaround for FY25, expecting a $1.75 million profit before tax driven by increased US sales and strategic operational shifts.

Wingara AG Limited reported an 18% revenue increase to $3.5 million for FY25 but posted a reduced net loss of $1.47 million, reflecting a strategic pause in fodder operations amid challenging market conditions.

Lucapa Diamond Company Limited’s shares remain suspended following the appointment of voluntary administrators, highlighting severe financial distress and regulatory breaches.

Humm Group reported a solid 10% increase in assets under management to $5.3 billion for 3Q25, maintaining stable margins while advancing a new hybrid loan product and IT platform modernization.

MyEco Group has secured $1.6 million through unsecured convertible notes to support a strategic operational restructure aimed at reducing costs and scaling production. This capital raise complements existing cash reserves and aims to improve margins while minimising shareholder dilution.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Cardiex Limited reported a $2.06 million cash outflow for Q3 2025 but is driving cost savings and new revenue streams while planning a capital raise to reach positive cash flow.